Jonathan Mant1, Richard J McManus, Rachel Hare. 1. Department of Primary Care and General Practice, Primary Care, University of Birmingham, Birmingham B15 2TT. j.w.mant@bham.ac.uk
Abstract
OBJECTIVE: To compare the characteristics of patients with cerebrovascular disease in primary care with those of the participants in the PROGRESS trial, on which national guidelines for blood pressure lowering are based. DESIGN: Population based cross sectional survey of patients with confirmed stroke or transient ischaemic attack. SETTING: Seven general practices in south Birmingham, England. PARTICIPANTS: All patients with a validated history of stroke (n = 413) or transient ischaemic attack (n = 107). PATIENT CHARACTERISTICS: age, sex, time since last cerebrovascular event, blood pressure, and whether receiving antihypertensive treatment. RESULTS: Patients were 12 years older than the participants in PROGRESS and twice as likely to be women. The median time that had elapsed since their cerebrovascular event was two and a half years, compared with eight months in PROGRESS. The systolic blood pressure of 315 (61%) patients was over 140 mm Hg, and for 399 (77%) it was over 130 mm Hg. One hundred and forty seven (28%) patients were receiving a thiazide diuretic, and 136 (26%) were receiving an angiotensin converting enzyme inhibitor. CONCLUSIONS: Important differences exist between the PROGRESS trial participants and a typical primary care stroke population, which undermine the applicability of the trial's findings. Research in appropriate populations is urgently needed before the international guidelines are implemented in primary care.
OBJECTIVE: To compare the characteristics of patients with cerebrovascular disease in primary care with those of the participants in the PROGRESS trial, on which national guidelines for blood pressure lowering are based. DESIGN: Population based cross sectional survey of patients with confirmed stroke or transient ischaemic attack. SETTING: Seven general practices in south Birmingham, England. PARTICIPANTS: All patients with a validated history of stroke (n = 413) or transient ischaemic attack (n = 107). PATIENT CHARACTERISTICS: age, sex, time since last cerebrovascular event, blood pressure, and whether receiving antihypertensive treatment. RESULTS:Patients were 12 years older than the participants in PROGRESS and twice as likely to be women. The median time that had elapsed since their cerebrovascular event was two and a half years, compared with eight months in PROGRESS. The systolic blood pressure of 315 (61%) patients was over 140 mm Hg, and for 399 (77%) it was over 130 mm Hg. One hundred and forty seven (28%) patients were receiving a thiazide diuretic, and 136 (26%) were receiving an angiotensin converting enzyme inhibitor. CONCLUSIONS: Important differences exist between the PROGRESS trial participants and a typical primary care stroke population, which undermine the applicability of the trial's findings. Research in appropriate populations is urgently needed before the international guidelines are implemented in primary care.
Authors: F Gueyffier; C Bulpitt; J P Boissel; E Schron; T Ekbom; R Fagard; E Casiglia; K Kerlikowske; J Coope Journal: Lancet Date: 1999-03-06 Impact factor: 79.321
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: B Williams; N R Poulter; M J Brown; M Davis; G T McInnes; J F Potter; P S Sever; S McG Thom Journal: J Hum Hypertens Date: 2004-03 Impact factor: 3.012
Authors: John Chalmers; Angela Todd; Neil Chapman; Lawrie Beilin; Stephen Davis; Geoffrey Donnan; Michael Frommer; Rachel Huxley; Claude Lenfant; Stephen MacMahon; Giuseppe Mancia; Shanthi Mendis; Judith Whitworth; Alberto Zanchetti Journal: J Hypertens Date: 2003-04 Impact factor: 4.844
Authors: P M Rothwell; A J Coull; M F Giles; S C Howard; L E Silver; L M Bull; S A Gutnikov; P Edwards; D Mant; C M Sackley; A Farmer; P A G Sandercock; M S Dennis; C P Warlow; J M Bamford; P Anslow Journal: Lancet Date: 2004-06-12 Impact factor: 79.321
Authors: Kate Fletcher; Jonathan Mant; Richard McManus; Sarah Campbell; Jonathan Betts; Clare Taylor; Satnam Virdee; Sue Jowett; Una Martin; Sheila Greenfield; Gary Ford; Nick Freemantle; F D Richard Hobbs Journal: BMC Cardiovasc Disord Date: 2010-08-09 Impact factor: 2.298
Authors: Liam G Glynn; Brian Buckley; Donal Reddan; John Newell; John Hinde; Sean F Dinneen; Andrew W Murphy Journal: Br J Gen Pract Date: 2008-07 Impact factor: 5.386
Authors: Kenneth Rockwood; Laura E Middleton; Paige K Moorhouse; Ingmar Skoog; Sandra E Black Journal: Clin Interv Aging Date: 2009-11-18 Impact factor: 4.458
Authors: Jocelyn Anderson; Liam G Glynn; John Newell; Alberto A Iglesias; Donal Reddan; Andrew W Murphy Journal: BMC Cardiovasc Disord Date: 2009-11-12 Impact factor: 2.298